NinaMED
PrivateLast Round
Seed
May 13, 2026
Total Funding Raised
$13.75M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
NinaMED is a healthtech company developing a non-invasive, wearable neuromodulation therapy for pelvic health disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Clinical Trials, Patient Engagement
Business Model
B2B2C
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NinaMED Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
NinaMED Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 13, 2026 |
NinaMED Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SPRIM Global Investments | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
$14M raised, led by SPRIM Global Investments.
NinaMED Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NinaMED's valuation, stock price, and market status.